$42.25
Price
$4.5B
Market Cap
51.5
P/E Ratio
26.3
Forward P/E
$0.82
EPS (TTM)
—
Dividend Yield
$372M
Cash
$6M
Total Debt
106M
Shares Out
$28.66
$91.00
52-Week Range
Institutional Ownership of CORCEPT THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for CORCEPT THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | +31.5% | 28.4K | $2M | $71.34 | |
| 2025-Q2 | |||||
| BUY | NEW | 21.6K | $2M | $71.71 | |
| 2023-Q2 | |||||
| SELL | EXIT | — | — | $22.97 | |
| 2023-Q1 | |||||
| BUY | NEW | 21.5K | $466296 | $21.77 | |
Insider Trading for CORCEPT THERAPEUTICS INC
6 Months Insider Sentiment
Buy $0
Sell $11.1M
0
Buys
14
Sells
-11.1M
Net
9
Grants
Largest
$3.2M
K
$2.1M
K
$1.5M
Guyer
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 06, 2026 | William Guyer | Chief Development Officer | SELL | 20.0K | $35.18 | $704K |
| Jan 06, 2026 | William Guyer | Chief Development Officer | EXERCISE | 20.0K | $21.65 | $433K |
| Jan 01, 2026 | BAKER G LEONARD JR | Director | GRANT | — | — | — |
| Dec 24, 2025 | Gary Charles Robb | Chief Business Officer | EXERCISE | 145.0K | $3.88 | $563K |
| Dec 24, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | GRANT | 243.2K | — | — |
| Dec 24, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | EXERCISE | 550.0K | $3.88 | $2.1M |
| Dec 12, 2025 | James N Wilson | Director | GRANT | 400.0K | — | — |
| Dec 02, 2025 | William Guyer | Chief Development Officer | SELL | 640 | $80.88 | $52K |
| Dec 02, 2025 | William Guyer | Chief Development Officer | SELL | 19.4K | $80.05 | $1.5M |
| Dec 02, 2025 | William Guyer | Chief Development Officer | EXERCISE | 20.0K | $21.65 | $433K |
| Dec 02, 2025 | William Guyer | Chief Development Officer | GRANT | 787 | — | — |
| Dec 01, 2025 | Joseph Douglas Lyon | Chief Accounting & Technology Officer | GRANT | 178 | $79.78 | $14K |
| Dec 01, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | SELL | 40.0K | $79.77 | $3.2M |
| Dec 01, 2025 | Gary Charles Robb | Chief Business Officer | GRANT | 224 | $79.78 | $18K |
| Dec 01, 2025 | Joseph Douglas Lyon | Chief Accounting & Technology Officer | EXERCISE | 5.0K | $13.56 | $68K |
| Dec 01, 2025 | Atabak Mokari | Chief Financial Officer | GRANT | 178 | $79.78 | $14K |
| Dec 01, 2025 | Joseph Douglas Lyon | Chief Accounting & Technology Officer | SELL | 5.0K | $79.53 | $398K |
| Dec 01, 2025 | William Guyer | Chief Development Officer | GRANT | 224 | $79.78 | $18K |
| Nov 25, 2025 | William Guyer | Chief Development Officer | SELL | 4.5K | $80.90 | $364K |
| Nov 17, 2025 | William Guyer | Chief Development Officer | GRANT | 5.3K | — | — |
| Nov 05, 2025 | William Guyer | Chief Development Officer | SELL | 13.2K | $75.64 | $996K |
| Nov 05, 2025 | William Guyer | Chief Development Officer | SELL | 300 | $76.28 | $23K |
| Nov 05, 2025 | William Guyer | Chief Development Officer | SELL | 6.5K | $74.75 | $489K |
| Nov 05, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | SELL | 10.8K | $75.14 | $814K |
| Nov 05, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | SELL | 3.6K | $75.98 | $273K |
| Nov 05, 2025 | William Guyer | Chief Development Officer | EXERCISE | 20.0K | $21.65 | $433K |
| Nov 05, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | SELL | 14.4K | $74.20 | $1.1M |
| Nov 03, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | SELL | 11.2K | $74.08 | $831K |
| Nov 03, 2025 | Joseph Douglas Lyon | Chief Accounting & Technology Officer | SELL | 5.0K | $73.65 | $368K |
| Nov 03, 2025 | Joseph Douglas Lyon | Chief Accounting & Technology Officer | EXERCISE | 5.0K | $13.56 | $68K |